Study reveals how SARS-CoV-2 variants lose Infectivity in aerosols: pH and salt content key factors

FHS
June 27, 2023
2:36 am

Research examines the stability of SARS-CoV-2 variants in aerosols, finding significant decay in infectivity over time. pH and salt content play a role in virus stability.

MSD mulls 2025/26 launch for RSV vaccine after Phase II/III win

Clesrovimab is a single dose extended half-life monoclonal antibody developed as a passive immunisation for the prevention of RSV. Image credit: Sergiy Palamarchuk / Shutterstock.

October 18, 2024

A VC-backed genetic testing startup to ‘consider’ making an offer to buy 23andMe

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 21, 2024

Acadia’s Nuplazid fails as treatment for schizophrenia in Phase 3 study

Acadia Pharmaceuticals said Monday that its approved medicine called Nuplazid failed to improve the social and emotional symptoms of schizophrenia in a late-stage clinical trial.

March 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.